Rchr
J-GLOBAL ID:200901011584445831   Update date: Feb. 14, 2024

Takai Akira

タカイ アキラ | Takai Akira
Affiliation and department:
Research field  (4): Medical biochemistry ,  Pharmacology ,  Clinical pharmacy ,  Physiology
Research keywords  (6): 薬理学一般 ,  医化学一般 ,  生理学一般 ,  Pharmacology ,  Biochemistry ,  Physiology
Research theme for competitive and other funds  (4):
  • 2001 - 2003 CFTR-塩素イオンチャネルの開閉調節に関与する新規Phosphataseの機能解析に関する研究
  • 2001 - 2003 毛様体筋収縮調節メカニズムヘの分子生物学的アプローチ
  • 2001 - 2003 Study on the functional properties of novel protein phosphatases involved in the regulation of CFTR-cholide channel
  • 2001 - 2003 Molecular-biological approach to the mechanism of visual accommodation
MISC (159):
Books (2):
  • Effects of protein phosphatase inhibitors on smooth muscles. (共著)
    In Recent Advances in Basic Mechanisms of Smooth Muscle Excitation,eds.BOLTON,T.B.& TOMITA,T.London : Academic Press (in the press) 1995
  • Contraction in vas deferens and myometrium during prolonged exposure to calcioum-free solution. (共著)
    In Calmodulin Antagonists and Cellular Physiology,eds.HIDAKA,H.& HARTSHORNE,D.J.New York : Academic Press. 1985
Works (2):
  • 生物発光における精密構造認識機構の解明と分子機構研究への展開
    1996 - 2000
  • Structure and functional control mechanism of biomolecules
    1996 - 2000
Education (2):
  • - 1979 Nagoya University School of Medicine
  • - 1979 Nagoya University Faculty of Medicine
Professional career (1):
  • (BLANK)
Work history (7):
  • 1999 - 2001 Associate Professor, Graduate School of
  • 2001 - - Professor, Asahikawa Medical College
  • 1988 - 1999 Associate Professor, Scool of Medicine,
  • 1986 - 1988 Lecture, School of Medicine, Nagoya University
  • 1979 - 1986 Research Associate, School of Medicine,
Show all
Committee career (2):
  • 1989 - 日本平滑筋学会 評議員
  • 1984 - 日本生理学会 評議員
Awards (1):
  • 1988 - ROSA-LOWIE AWARD
Association Membership(s) (4):
Biophysical Society (USA) ,  日本生物物理学会 ,  日本平滑筋学会 ,  日本生理学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page